Drug price hikes without proof of new benefits cost the U.S. $815M last year

The findings were released amid ongoing national turmoil over the cost of prescription drugs

December 12, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds The nonprofit ICER said the price increases exceeded the medical consumer price index and occurred without evidence of new benefits from the drugs. By Ed Silverman STAT+ | Investors in Padlock Therapeutics sue Bristol Myers Squibb over 'milestone' payments The case reveals a darker side to the so-called "biobucks" deal structure that has become ubiquitous in the biotech and pharmaceutical industry. By Adam Feuerstein STAT+ | Centene warns Republicans against cutting Medicaid or letting ACA subsidies expire Health insurer Centene is counting on government programs to help it expand profit margins next year. By Bob Herman Adobe STAT+ | AI versus AI: The emerging arms race over health insurance denials As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go uncontested. By Casey Ross STAT+ | Arcellx won the battle of BCMA CAR-T therapies Data presented at the ASH meeting made a convincing case for a meaningful safety differentiation favoring anito-cel over Carvykti. By Adam Feuerstein STAT+ | Why Stoke Therapeutics' Dravet syndrome drug is worth watching The company is hoping that a planned clinical trial will set its treatment called zorevunersen apart from existing therapies. By Adam Feuerstein Kevin Dietsch/AP STAT+ | Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds At issue is concern the big PBMs — controlled by CVS Health, Cigna, and UnitedHealth Group — favor their own mail order or retail pharmacies. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser